Journal of Experimental Medicine,
New study shows that about two percent of the population develop autoantibodies against type 1 interferons, mostly later in life.
New study shows that about two percent of the population develop autoantibodies against type 1 interferons, mostly later in life.
Rare autoantibodies neutralizing type I IFNs can underlie viral disease severity. Here, Sonja Fernbach, Nina Mair, Benjamin…